| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients
|
Moreno, G.
|
|
|
47 |
1 |
p. 23-33
|
article
|
| 2 |
Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients
|
Gabara, C.
|
|
|
47 |
1 |
p. 1-8
|
article
|
| 3 |
Antiseptic mouthwashes and mortality: look beyond chlorhexidine
|
Blot, S.
|
|
|
47 |
1 |
p. 55-56
|
article
|
| 4 |
Assessment of plasma endocan for the prediction of mortality in COVID-19 patients undergoing veno-venous ECMO: A pilot study
|
Levy, C.
|
|
|
47 |
1 |
p. 51-54
|
article
|
| 5 |
COVID-19 associated pulmonary aspergillosis
|
Álvarez Fernández, M.
|
|
|
47 |
1 |
p. 62-63
|
article
|
| 6 |
Ghost cannula after ECMO removal
|
Martínez-Solano, J.
|
|
|
47 |
1 |
p. 60-61
|
article
|
| 7 |
How and when should a CO2 removal device be used?
|
de Pablo, R.
|
|
|
47 |
1 |
p. 45-47
|
article
|
| 8 |
Lung ultrasound protocol decreases radiation in newborn population without side effects: A quality improvement project
|
Rodriguez-Fanjul, J.
|
|
|
47 |
1 |
p. 16-22
|
article
|
| 9 |
Multicenter validation of Early Warning Scores for detection of clinical deterioration in COVID-19 hospitalized patients
|
Huespe, I.A.
|
|
|
47 |
1 |
p. 9-15
|
article
|
| 10 |
Myocardial injury as a prognostic factor in critically ill patients with severe SARS-Cov-2 pneumonia
|
Villavicencio, C.
|
|
|
47 |
1 |
p. 48-51
|
article
|
| 11 |
Peripheral pulmonary thromboembolism in COVID-19 bilateral pneumonia
|
Vela Colmenero, R.M.
|
|
|
47 |
1 |
p. 58-59
|
article
|
| 12 |
Reply to “Antiseptic Mouthwashes and Mortality: Look Beyond Chlorhexidine”
|
Vieira, P.C.
|
|
|
47 |
1 |
p. 56-57
|
article
|
| 13 |
Treatment of severe infections caused by ESBL or carbapenemases-producing Enterobacteriaceae
|
Lombardi, G.
|
|
|
47 |
1 |
p. 34-44
|
article
|
Journal description